Unrecognized drug-drug interactions: A cause of intraoperative cardiac arrest?

Anesthesia and Analgesia

Volumn 102, Issue 5, 2006, Pages 1569-1572

  Marcucci, Catherine ^a   Sandson, Neil B ^a,c   Thorn, Eric M ^b   Bourke, Denis L ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND MEDICAL SYSTEM   (United States)

^c SHEPPARD PRATT HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ADRENALIN; AMITRIPTYLINE; ATROPINE; CAFFEINE; CYCLOBENZAPRINE; DOPAMINE RECEPTOR; EPHEDRINE; INSULIN; LOCAL ANESTHETIC AGENT; MEPIVACAINE; METOPROLOL; NIFEDIPINE; NORADRENALIN; NORTRIPTYLINE; OMEPRAZOLE; PHENYLEPHRINE; SERTRALINE; TETRACAINE;

ADULT; ARTICLE; BRADYCARDIA; CASE REPORT; FOOD DRUG INTERACTION; GRAPEFRUIT JUICE; HEART ARREST; HEART ARRHYTHMIA; HEART RHYTHM; HUMAN; HYPOTENSION; MALE; PREOPERATIVE PERIOD; PRIORITY JOURNAL; REGIONAL ANESTHESIA;

EID: 33646197780     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ane.0000204290.54768.cc     Document Type: Article

References (19)

1. Cox B, Durieux ME, Marcus MA. Toxicity of local anaesthetics. Best Pract Res Clin Anaesthesiol 2003;17:111-36.
2. Tagariello V, Caporuscio A, De Tommaso O. Mepivacaine: update on an evergreen local anaesthetic. Minerva Anestesiol 2001;67:5-8.
3. Fuhr U. Drug interactions with grapefruit juice: extent, probable mechanism and clinical relevance. Drug Saf 1998;18:251-72.
4. Hartter S, Nordmark A, Rose DM, et al. Effects of caffeine intake on the pharmacokinetics of melatonin, a probe drug for CYP1A2 activity. Br J Clin Pharmacol 2003;56:679-82.
5. von Moltke LL, Greenblatt DJ, Duan SX, et al. Phenacetin O-deethylation by human liver microsomes in vitro: inhibition by chemical probes, SSRI antidepressants, nefazodone and venlafaxine. Psychopharmacology (Berl) 1996;128:398-407.
6. Ekstrom G, Gunnarsson UB. Ropivacaine, a new amide-type local anesthetic agent, is metabolized by cytochromes P450 1A and 3A in human liver microsomes. Drug Metab Dispos 1996;24:955-61.
7. Hattis D, Russ A, Banati P, et al. Background and user's guide: comparative child/adult pharmacokinetic database based upon the therapeutic drug literature. Worcester, MA: Clark University, 2001:5-6.
8. Venkatakrishnan K, Greenblatt DJ, von Moltke LL, et al. Five distinct human cytochromes mediate amitriptyline N-demethylation in vitro: dominance of CYP 2C19 and 3A4. J Clin Pharmacol 1998;38:112-21.
9. Olesen OV, Linnet K. Metabolism of the tricyclic antidepressant amitriptyline by cDNA-expressed human cytochrome P450 enzymes. Pharmacology 1997;55:235-43.
10. Wang RW, Liu L, Cheng H. Identification of human liver cytochrome P450 isoforms involved in the in vitro metabolism of cyclobenzaprine. Drug Metab Dispos 1996;24:786-91.
11. Flexeril. In: The Merck Index. West Point, PA: Merck & Co., Inc., 2003.
12. Schrenk D, Brockmeier D, Morike K, et al. A distribution study of CYP1A2 phenotypes among smokers and non-smokers in a cohort of healthy Caucasian volunteers. Eur J Clin Pharmacol 1998;53:361-7.
13. Zevin S, Benowitz NL. Drug interactions with tobacco smoking: an update. Clin Pharmacokinet 1999;36:425-38.
14. Kirchheiner J, Heesch C, Bauer S, et al. Impact of the ultrarapid metabolizer genotype of cytochrome P450 2D6 on metoprolol pharmacokinetics and pharmacodynamics. Clin Pharmacol Ther 2004;76:302-12.
15. Solai LK, Mulsant BH, Pollock BG, et al. Effect of sertraline on plasma nortriptyline levels in depressed elderly. J Clin Psychiatry 1997;58:440-3.
16. Kobayashi K, Yamamoto T, Chiba K, et al. The effects of selective serotonin reuptake inhibitors and their metabolites on S-mephenytoin 4′-hydroxylase activity in human liver microsomes. Br J Clin Pharmacol 1995;40:481-5.
17. Lill J, Bauer LA, Horn JR, Hansten PD. Cyclosporine-drug interactions and the influence of patient age. Am J Health Syst Pharm 2000;57:1579-84.
18. Shin JG, Park JY, Kim MJ, et al. Inhibitory effects of tricyclic antidepressants (TCAs) on human cytochrome P450 enzymes in vitro: mechanism of drug interaction between TCAs and phenytoin. Drug Metab Dispos 2002;30:1102-7.
19. Zineh I, Beitelshees AL, Gaedigk A, et al. Pharmacokinetics and CYP2D6 genotypes do not predict metoprolol adverse events or efficacy in hypertension. Clin Pharmacol Ther 2004;76:536-44.